• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于开发荧光分光光度法测定法维拉韦的实验设计方法;一种针对 COVID-19 病毒的潜在治疗剂:在加标人血浆中的应用。

Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.

机构信息

Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

Department of Pharmaceutical Analytical Chemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt.

出版信息

Spectrochim Acta A Mol Biomol Spectrosc. 2021 Mar 15;249:119241. doi: 10.1016/j.saa.2020.119241. Epub 2020 Nov 28.

DOI:10.1016/j.saa.2020.119241
PMID:33333412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7834856/
Abstract

The present work describes development of rapid, robust, sensitive and green spectrofluorimetric method for determination of favipiravir (FAV). Different factors affecting fluorescence were carefully studied and Box Behnken Design was applied to optimize experimental parameters. The proposed method is based on measuring native fluorescence of FAV in 0.2 M borate buffer (pH 8.0) at 432 nm after excitation at 361 nm. There was a linear relationship between FAV concentration and relative fluorescence intensity over the range 40-280 ng/mL with limit of detection of 9.44 ng/mL and quantitation limit of 28.60 ng/mL. The method was successfully implemented for determination of FAV in its pharmaceutical formulation with mean % recovery of 99.26 ± 0.87. Moreover, the high sensitivity of the method allowed determination of FAV in spiked human plasma over a range of 48-192 ng/mL. The proposed spectrofluorimetric method was proved to be eco-friendly according to analytical eco-scale.

摘要

本工作描述了一种快速、灵敏、绿色的荧光分光光度法测定法维拉韦(FAV)的方法。仔细研究了影响荧光的不同因素,并应用 Box-Behnken 设计对实验参数进行了优化。该方法基于在 0.2 M 硼酸盐缓冲液(pH 8.0)中测量 FAV 的本征荧光,在 361nm 激发下于 432nm 处测定。FAV 浓度与相对荧光强度在 40-280ng/mL 范围内呈线性关系,检出限为 9.44ng/mL,定量限为 28.60ng/mL。该方法成功地用于测定其药物制剂中的 FAV,平均回收率为 99.26±0.87%。此外,该方法的高灵敏度允许在 48-192ng/mL 的范围内测定人血浆中加标的 FAV。根据分析生态标度,所提出的荧光分光光度法被证明是环保的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/49d48f197e66/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/fc3f813dee58/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/60ac1fc0bb4b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/bf99123a8608/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/4d1bc7873171/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/49d48f197e66/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/fc3f813dee58/ga1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/60ac1fc0bb4b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/bf99123a8608/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/4d1bc7873171/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0dfa/7834856/49d48f197e66/gr4_lrg.jpg

相似文献

1
Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma.用于开发荧光分光光度法测定法维拉韦的实验设计方法;一种针对 COVID-19 病毒的潜在治疗剂:在加标人血浆中的应用。
Spectrochim Acta A Mol Biomol Spectrosc. 2021 Mar 15;249:119241. doi: 10.1016/j.saa.2020.119241. Epub 2020 Nov 28.
2
An ultrasensitive green synchronous factorized spectrofluorimetric approach for the simultaneous determination of Favipiravir and Molnupiravir: Application to pharmaceutical, environmental, and biological matrices.一种超灵敏的绿色同步因子分解荧光光谱法用于同时测定法维拉韦和莫那比拉韦:在药物、环境和生物基质中的应用。
Luminescence. 2024 Aug;39(8):e4837. doi: 10.1002/bio.4837.
3
Development and validation of a sensitive, fast and simple LC-MS / MS method for the quantitation of favipiravir in human serum.建立并验证一种灵敏、快速、简单的 LC-MS/MS 方法,用于人血清中法维拉韦的定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Jun 30;1176:122768. doi: 10.1016/j.jchromb.2021.122768. Epub 2021 May 20.
4
Development and Validation of a Method for Quantification of Favipiravir as COVID-19 Management in Spiked Human Plasma.开发和验证一种用于检测人血浆中添加的法匹拉韦以管理 COVID-19 的方法。
Molecules. 2021 Jun 22;26(13):3789. doi: 10.3390/molecules26133789.
5
Core-shell nanocomposite of flower-like molybdenum disulfide nanospheres and molecularly imprinted polymers for electrochemical detection of anti COVID-19 drug favipiravir in biological samples.花状二硫化钼纳米球和分子印迹聚合物的核壳纳米复合材料用于生物样品中环丙沙星的电化学检测
Mikrochim Acta. 2022 Mar 1;189(3):125. doi: 10.1007/s00604-022-05213-9.
6
Eco-friendly novel deconvoluted synchronous spectrofluorimetric approach for the determination of favipiravir, levodropropizine and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in laboratory prepared mixtures and spiked human plasma.用于测定法匹拉韦、左羟丙哌嗪和盐酸莫西沙星作为COVID-19有效治疗组合的环保型新型解卷积同步荧光光谱法;在实验室制备混合物和加标人血浆中的应用
Spectrochim Acta A Mol Biomol Spectrosc. 2024 Mar 15;309:123823. doi: 10.1016/j.saa.2023.123823. Epub 2023 Dec 31.
7
Menthol-assisted homogenous liquid-liquid microextraction for HPLC/UV determination of favipiravir as an antiviral for COVID-19 in human plasma.薄荷醇辅助均相液相微萃取-高效液相色谱/紫外检测法测定人血浆中用于治疗 COVID-19 的抗病毒药物法维拉韦。
J Chromatogr B Analyt Technol Biomed Life Sci. 2022 Jan 15;1189:123087. doi: 10.1016/j.jchromb.2021.123087. Epub 2021 Dec 29.
8
Favipiravir for COVID-19 in a Patient on Hemodialysis.法匹拉韦用于一名接受血液透析的新冠肺炎患者的治疗
Am J Kidney Dis. 2021 Jan;77(1):153-154. doi: 10.1053/j.ajkd.2020.09.007. Epub 2020 Oct 1.
9
Determination of favipiravir in human plasma using homogeneous liquid-liquid microextraction followed by HPLC/UV.采用均相液-液微萃取结合高效液相色谱/紫外检测法测定人血浆中珐匹拉韦的浓度。
Bioanalysis. 2022 Feb;14(4):205-216. doi: 10.4155/bio-2021-0219. Epub 2022 Jan 10.
10
Synchronous spectrofluorimetric determination of favipiravir and aspirin at the nano-gram scale in spiked human plasma; greenness evaluation.纳米级人血浆中扎那米韦和阿司匹林的同步荧光光度法测定;绿色度评价。
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Oct 15;299:122880. doi: 10.1016/j.saa.2023.122880. Epub 2023 May 16.

引用本文的文献

1
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma.用于测定新冠病毒治疗药物法匹拉韦和硝唑尼特的生态可持续色谱法:应用于人体血浆
BMC Chem. 2025 Jan 9;19(1):11. doi: 10.1186/s13065-024-01364-3.
2
Insights into the sustainability of liquid chromatographic methods for favipiravir bioanalysis: a comparative study.法匹拉韦生物分析液相色谱方法可持续性的见解:一项比较研究。
RSC Adv. 2024 Jun 18;14(28):19658-19679. doi: 10.1039/d4ra03017f.
3
Green chemometric-assisted UV-spectrophotometric methods for the determination of favipiravir, cefixime and moxifloxacin hydrochloride as an effective therapeutic combination for COVID-19; application in pharmaceutical form and spiked human plasma.

本文引用的文献

1
Comparison of HPLC and UV Spectrophotometric Methods for Quantification of Favipiravir in Pharmaceutical Formulations.高效液相色谱法与紫外分光光度法用于药物制剂中法匹拉韦定量分析的比较
Iran J Pharm Res. 2021 Summer;20(3):57-65. doi: 10.22037/ijpr.2020.114199.14725.
2
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an perspective.靶向 SARS-CoV-2 RNA 依赖性 RNA 聚合酶(RdRp):一个研究视角。
J Biomol Struct Dyn. 2021 Jun;39(9):3204-3212. doi: 10.1080/07391102.2020.1761882. Epub 2020 May 6.
3
A Novel Coronavirus from Patients with Pneumonia in China, 2019.
绿色化学计量学辅助紫外分光光度法测定法匹拉韦、头孢克肟和盐酸莫西沙星作为COVID-19的有效治疗组合;在药物剂型和加标人血浆中的应用
BMC Chem. 2024 Apr 5;18(1):65. doi: 10.1186/s13065-024-01168-5.
4
A solvent-free HPLC method for the simultaneous determination of Favipiravir and its hydrolytic degradation product.一种无溶剂高效液相色谱法,用于同时测定法维拉韦及其水解降解产物。
Sci Rep. 2023 Oct 28;13(1):18512. doi: 10.1038/s41598-023-45618-x.
5
Spectrophotometric determination of favipiravir in presence of its acid hydrolysis product.在其酸水解产物存在的情况下,用分光光度法测定法匹拉韦。
BMC Chem. 2023 Sep 30;17(1):129. doi: 10.1186/s13065-023-01046-6.
6
Electroanalytical investigation and voltammetric quantification of antiviral drug favipiravir in the pharmaceutical formulation and urine sample using a glassy carbon electrode in anionic surfactant media.在阴离子表面活性剂介质中使用玻碳电极对药物制剂和尿液样本中的抗病毒药物法匹拉韦进行电分析研究和伏安法定量。
Turk J Chem. 2022 Feb 23;46(3):869-880. doi: 10.55730/1300-0527.3375. eCollection 2022.
7
A highly sensitive and green electroanalytical method for the determination of favipiravir in pharmaceutical and biological fluids.一种用于测定药物和生物流体中法匹拉韦的高灵敏度绿色电分析方法。
BMC Chem. 2023 Aug 31;17(1):109. doi: 10.1186/s13065-023-01023-z.
8
An Efficient Electrochemical Sensor Based on NiCoO Nanoplates and Ionic Liquid for Determination of Favipiravir in the Presence of Acetaminophen.基于 NiCoO 纳米片和离子液体的电化学传感器用于在对乙酰氨基酚存在下测定法匹拉韦。
Biosensors (Basel). 2023 Aug 14;13(8):814. doi: 10.3390/bios13080814.
9
LC-MS/MS Method Development and Validation for Determination of Favipiravir Pure and Tablet Dosage Forms.用于测定法匹拉韦原料药及片剂剂型的液相色谱-串联质谱法的方法开发与验证
Turk J Pharm Sci. 2023 Aug 22;20(4):226-233. doi: 10.4274/tjps.galenos.2022.75470.
10
The application of multi-walled carbon nanotubes modified pencil graphite electrode for voltammetric determination of favipiravir used in COVID-19 treatment.多壁碳纳米管修饰铅笔石墨电极在伏安法测定用于COVID-19治疗的法匹拉韦中的应用。
Monatsh Chem. 2023 Jun 8:1-11. doi: 10.1007/s00706-023-03082-3.
2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
4
GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline.海湾合作委员会向国际人用药品注册技术协调会提交的关于《2019年国际人用药品注册技术协调会M10生物分析方法验证指南草案》的综合反馈意见。
Bioanalysis. 2019 Sep;11(18s):1-228. doi: 10.4155/bio-2019-0207. Epub 2019 Sep 30.
5
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase.法匹拉韦(T-705),一种病毒RNA聚合酶的广谱抑制剂。
Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(7):449-463. doi: 10.2183/pjab.93.027.
6
T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug.T-705(法匹拉韦)可抑制流感病毒感染后肿瘤坏死因子α的产生:T-705作为一种抗流感药物的有益特性。
Acta Virol. 2017;61(1):48-55. doi: 10.4149/av_2017_01_48.
7
Clinical and Virological Characteristics of Ebola Virus Disease Patients Treated With Favipiravir (T-705)-Sierra Leone, 2014.2014 年塞拉利昂接受法匹拉韦(T-705)治疗的埃博拉病毒病患者的临床和病毒学特征。
Clin Infect Dis. 2016 Nov 15;63(10):1288-1294. doi: 10.1093/cid/ciw571. Epub 2016 Aug 23.
8
Application of quality by design to the development of analytical separation methods.质量源于设计在分析分离方法开发中的应用。
Anal Bioanal Chem. 2013 Jan;405(2-3):443-50. doi: 10.1007/s00216-012-6302-2. Epub 2012 Sep 2.
9
Box-Behnken design: an alternative for the optimization of analytical methods.Box-Behnken设计:一种优化分析方法的替代方案。
Anal Chim Acta. 2007 Aug 6;597(2):179-86. doi: 10.1016/j.aca.2007.07.011. Epub 2007 Jul 23.
10
Design of experiment and data analysis by JMP (SAS institute) in analytical method validation.在分析方法验证中使用JMP(SAS研究所)进行实验设计和数据分析。
J Pharm Biomed Anal. 2000 Aug 15;23(2-3):581-9. doi: 10.1016/s0731-7085(00)00335-6.